UNIVERSITY OF MARYLAND ONCOLOGY ASSOCIATES PA
Balance Sheet
Fiscal Year Start:
Jul 1
Assets in 2024 (Year End)
$4,830,489
Cash & Equivalents
74%
Receivables (Non-Related)
18%
Other Assets
7%
Related-Party Receivables
0%
Inventories
0%
Prepaid Expenses
0%
Investments
0%
Property, Plant, & Equipment (net)
0%
Liabilities in 2024 (Year End)
$5,270,179
Payables & Accruals
60%
Other Liabilities
35%
Deferred Revenue
5%
Grants Payable
0%
Tax-Exempt Bond Liabilities
0%
Custodial & Escrow Liabilities
0%
Notes Payable / Debt (Non-Related)
0%
Related-Party Payables
0%
Assets
2023
2024
Change
Cash & Equivalents
$2,230,738
$3,588,498
+61%
Receivables (Non-Related)
$662,557
$883,701
+33%
Related-Party Receivables
$0
$0
-
Inventories
$0
$0
-
Prepaid Expenses
$0
$0
-
Investments
$0
$0
-
Property, Plant, & Equipment (net)
$0
$0
-
Other Assets
$383,176
$358,290
-6%
Total Assets
$3,276,471
$4,830,489
+47%
Liabilities
2023
2024
Change
Payables & Accruals
$2,459,062
$3,176,577
+29%
Grants Payable
$0
$0
-
Deferred Revenue
$206,901
$253,970
+23%
Tax-Exempt Bond Liabilities
$0
$0
-
Custodial & Escrow Liabilities
$0
$0
-
Notes Payable / Debt (Non-Related)
$0
$0
-
Related-Party Payables
$0
$0
-
Other Liabilities
$1,794,126
$1,839,632
+3%
Total Liabilities
$4,460,089
$5,270,179
+18%
Net assets
2023
2024
Change
Restricted Net Assets
$0
$0
-
Unrestricted Net Assets
-$1,183,618
-$439,690
+63%
Net assets
2023
2024
Change
Net assets
-$1,183,618
-$439,690
+63%
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)